Inside the research
Agilent Technologies, Inc.
A Research profile · latest available data
Price overview
$172.79
▼ -0.05 (-0.0%)
| 52w hi | $172.84 |
|---|---|
| 52w lo | $109.78 |
| Vol | 2.58M |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.41
| Short | +0.37 |
|---|---|
| Medium | +0.52 |
| Long | +0.27 |
computed 2026-09-27
Key fundamentals
Agilent Technologies, Inc.
Healthcare · Diagnostics & Research
| Market cap | $48.72B |
|---|---|
| Enterprise value | $51.10B |
| Trailing P/E | 34.15x |
| Forward P/E | 25.57x |
| EV / EBITDA | 24.57x |
| P / S (ttm) | 6.61x |
| Profit margin | 19.5% |
| Return on equity | 21.0% |
| Revenue growth | +8.1% |
| Earnings growth | +8.5% |
| Debt / equity | 56.34 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.19 | |
| Sector | +0.08 | |
| Technical | +0.30 | |
| Earnings | +0.00 | |
| Sentiment | -0.01 |
macro × 1.00 · 2026-09-27
Business overview
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Risk Metrics
| Beta vs SPX | 0.99 |
|---|---|
| Corr SPX | 0.49 |
| Annual vol | 32.2% |
| Annual ret | +15.6% |
| Sharpe | 0.48 |
| Max DD | -34.9% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $160.69 |
|---|---|
| High / Low | $185.00 / $140.00 |
| Median | $159.50 |
| Analysts | 16 |
| Strong Buy | 4 | |
|---|---|---|
| Buy | 10 | |
| Hold | 4 | |
| Sell | 0 | |
| Strong Sell | 0 |
Recent rating actions
| 2026-04-28 | Keybanc | → Sector Weight |
| 2026-04-14 | Barclays | → Overweight |
| 2026-04-13 | TD Cowen | → Buy |
| 2026-04-06 | Evercore ISI Group | → Outperform |
| 2026-03-03 | Morgan Stanley | → Overweight |
| 2026-02-26 | Wells Fargo | → Overweight |
Officers & Board
| CEO | Padraig McDonnell since 2024 |
|---|---|
| Director | Padraig McDonnell since 2024 |
| Director | Otis Brawley since 2021 |
| Director | Mikael Dolsten since 2021 |
| Director | Mala Anand since 2019 |
| Director | Dow R. Wilson since 2018 |
| Director | Hans Bishop since 2017 |
| Director | Sue H. Rataj since 2015 |
| Director | Daniel K. Podolsky since 2015 |
| Director | George Scangos since 2014 |
| Director | Koh Boon Hwee since 2003 |
| Director | Heidi K. Kunz since 2000 |
| Founder | William Redington Hewlett current |
| CEO | Michael R. McMullen 2015–2024 |
| Director | Michael R. McMullen 2015–2024 |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-06-25 | Material Agreement, Material Obligation… | read |
| 2026-05-27 | Earnings Release, Officer / Director Change… | read |
| 2026-05-04 | Officer / Director Change, Reg FD Disclosure… | read |
| 2026-04-03 | 5.01, Exhibits | read |
| 2026-03-20 | Bylaws Amendment, Shareholder Vote… | read |
| 2026-03-06 | Officer / Director Change, Exhibits | read |
| 2026-02-25 | Earnings Release, Exhibits | read |
| 2025-11-24 | Earnings Release, Exhibits | read |
| 2025-10-27 | Officer / Director Change | read |
| 2025-08-27 | Earnings Release, Exhibits | read |
| 2025-07-15 | Officer / Director Change, Reg FD Disclosure… | read |
| 2025-05-28 | Earnings Release, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-26 | KIRKWOOD JONAH PREVOST | Senior Vice President | Withheld for tax | 30 | $4.08K |
| 2026-06-03 | MCDONNELL PADRAIG | President and CEO | Withheld for tax | 418 | $57.43K |
| 2026-05-29 | Dolsten Mikael | Sell | 1.60K | $216.67K | |
| 2026-05-19 | Buckner Michael Steven | Senior Vice President | Grant | 8.87K | — |
| 2026-05-08 | MAY SIMON | Senior Vice President | Withheld for tax | 368 | $42.55K |
| 2026-03-31 | Henson Meghan | Senior Vice President | Withheld for tax | 153 | $17.44K |
| 2026-03-19 | Rataj Sue H. | Grant | 2.16K | $241.16K | |
| 2026-03-19 | Soriot Pascal | Withheld for tax | 648 | $72.41K | |
| 2026-03-19 | BRAWLEY OTIS W | Grant | 2.16K | $241.16K | |
| 2026-03-19 | BRAWLEY OTIS W | Grant | 888 | $99.23K |
Flow & Concentration
| Insider 180d net | -$216.67K |
|---|---|
| Insider buys / sells | 0 / 1 |
| Insider bias | Neutral |
| 13F holders | 8 |
| Top-5 share | 99.4% |
| HHI | 3,403 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $1.71B | 12.85M |
| Fidelity / FMR LLC | $674.27M | 5.08M |
| AQR Capital Management | $472.36M | 3.60M |
| Capital Research / Capital World | $212.24M | 1.60M |
| Citadel Advisors | $203.66M | 1.53M |
| Millennium Management | $16.70M | 125.74K |
| Bridgewater Associates | $3.04M | 22.89K |
| T. Rowe Price Group | $134.79K | 1.01M |
As of 2026-06-30
Connections
Subsidiarys: Agilent CrossLab Group
Dividends
| Yield (TTM) | 0.44% |
|---|---|
| $ / share (TTM) | $0.76 |
| 5y CAGR | +6.6% |
Annual dividend per share
| 2021 | $0.78 |
|---|---|
| 2022 | $1.06 |
| 2023 | $0.91 |
| 2024 | $0.96 |
| 2025 | $0.74 |
| 2026 | $0.51 |
SEC Filings
The Long Run
FY 2009–2025 · 17 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $6.95B | +2.8% | |
| Operating income | $1.35B | +23.4% | |
| Net income | $1.29B | +0.9% | |
| Cash from ops | $1.75B | +3.8% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $171.98 | $172.94 | $169.43 | $172.79 | 2.58M |
| Sep 24 | $163.95 | $174.77 | $163.62 | $172.84 | 3.05M |
| Sep 23 | $166.54 | $168.94 | $163.27 | $165.32 | 3.24M |
| Sep 22 | $163.08 | $167.59 | $161.04 | $167.26 | 3.78M |
| Sep 21 | $157.87 | $162.89 | $157.08 | $161.94 | 2.71M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →